The accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer
Wiener HG, Vooijs GP, van't Hof-Grootenboer B, et al.: The accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer. Acta Cytol 37: 163-167, 1993
Clinical evaluation of Nuclear Matrix Protein 22 (NMP22) in urine as a novel marker for urothelial cancer
Miyanaga N, Akaza H, Ishikawa S, et al.: Clinical evaluation of Nuclear Matrix Protein 22 (NMP22) in urine as a novel marker for urothelial cancer. Eur Urol 31: 163-168, 1997
Evaluation of nuclear matrix protein 22 as a tumor marker in the detection of transitional cell carcinoma of the bladder
Sänchez-Carbayo M, Herrero EJ, Megias J, et al.: Evaluation of nuclear matrix protein 22 as a tumor marker in the detection of transitional cell carcinoma of the bladder. Br J Urol 84: 706-713, 1999
Use of a new tumor marker, urinary NMP22 in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment
Soloway MS, Brïggman JV, Carpinito GA, et al.: Use of a new tumor marker, urinary NMP22 in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J Urol 156: 363-367, 1996
Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder
Stampfer DS, Carpinito GA, Rodriguez-Villanueva J, et al.: Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder. J Urol 159: 394-398, 1998
Sensitivity and specificity of NMP22, telomerase, and BTA in the detection of human bladder cancer
Landman J, Chang Y, Kavaler E, et al.: Sensitivity and specificity of NMP22, telomerase, and BTA in the detection of human bladder cancer. Urology 52: 398-402, 1998